Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via AOL· 3 weeks agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
A Bull Market Is Here: 2 Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 months agoWith the S&P 500 index recently hitting a new all-time high, we can officially declare that we are...
Q3 Earnings Season Scorecard and Analyst Reports for Merck, Bank of America & AMD
Zacks via Yahoo Finance· 7 months agoThursday, November 2, 2023 The Zacks Research Daily presents the best research output of our analyst...
The Zacks Analyst Blog Highlights J&J, AstraZeneca, Merck, Seagen and Pfizer
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 10, 2023 – Zacks.com announces the list of stocks featured...
The Zacks Analyst Blog Highlights Merck, Bank of America, AMD, Netflix and Union Pacific
Zacks via Yahoo Finance· 7 months agoFor Immediate Release Chicago, IL – November 3, 2023 – Zacks.com announces the list of stocks...
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – November 23, 2022 – Zacks.com announces the list of stocks...
Merck's Deal With Seagen May Have Fallen Through. Now What?
Motley Fool· 2 years agoFollowing months of speculation over pharmaceutical giant Merck's (NYSE: MRK) potential takeover of cancer-focused biotech Seagen (NASDAQ: SGEN), reports are now surfacing that the two companies ...
Patients seek relief from spiraling drug prices. Will the Inflation Reduction Act deliver?
USA TODAY via Yahoo News· 2 years agoJackie Trapp has incurable blood cancer and takes a chemotherapy drug that cost more than $240,000...
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back...
Benzinga via Yahoo Finance· 4 months agoOn Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer...
2 Stocks Down 36% or More to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 3 months agoThere's arguably no better time to buy a stock than when it's been beaten down. Doing so provides a...